Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Closes Mixed As Oil Prices Resume Fall

Mon, 12th Jan 2015 17:11

LONDON (Alliance News) - UK shares gave up their earlier gains Monday as oil prices resumed their slide, while European stocks were boosted by a report setting out the mechanics of a widely anticipated quantitative easing programme by the European Central Bank.

In a day with little fresh economic data, London shares opened higher and maintained their gains for most of the trading session. However, the FTSE 100 and FTSE 250 indices incurred sharp losses after US indices quickly overturned a higher open, though the FTSE 100 managed to recover somewhat in late trade.

The FTSE 100 closed flat at 6,501.42, while the FTSE 250 closed down 0.4% at 15,943.69. The small-cap AIM All-Share managed a gain, however, closing 0.1% higher at 703.92.

Stocks in mainland Europe outperformed London, as talk of ECB quantitative easing drove equities. CNBC reported Monday that the ECB could be set to reveal a program of quantitative easing whereby the amount of sovereign debt to be purchased by the ECB would be determined by the level of contributions made by each national central bank within the eurozone.

The next ECB monetary policy decision announcement and press conference by President Mario Draghi is set for January 22.

The CAC 40 in Paris ended up 1.2%, and the DAX 30 in Frankfurt closed up 1.4%.

At the London close, Wall Street was trading broadly lower. The DJIA was down 0.4%, the S&P 500 and Nasdaq Composite were both down 0.6%. The fourth-quarter reporting season in the US will get underway Monday with the release of aluminium producer Alcoa's fourth-quarter earnings report after the close of US trading.

Oil prices continued their downward path, with Brent falling below USD48 a barrel for the first time since the end of March 2009. At its lowest level of the day, Brent touched USD47.16 a barrel. The US benchmark West Texas Intermediate dropped to its lowest level since late April 2009. WTI hit a low of USD45.88 a barrel.

Oil-related stocks were amongst the biggest fallers in the FTSE 100 and FTSE 250. BG Group, down 3.6%, and Royal Dutch Shell 'B', down 1.6%, were amongst the biggest blue-chip losers. Hunting, down 8.1%, Premier Oil, down 6.7%, John Wood Group and SOCO International, both down 4.9%, Ophir Energy, down 4.8%, and Petrofac and Cairn Energy, both down 4.3%, were amongst the worst mid-cap performers.

Gold miners Fresnillo, up 1.1%, and Randgold Resources, up 1.0%, benefited as gold prices rose towards the end of trade. Gold rose to a high of USD1,231.23 an ounce, the yellow metal's highest level since December 11.

Afren, down 22%, was by far the biggest faller in the FTSE 250, hitting its lowest level since the end of March 2009. The oil and gas explorer said it is considering its options for the Barda Rash field in the Kurdistan region of Iraq after the reserve estimate for the prospect was revised down substantially.

Afren said an updated competent person's report on the Barda Rash field is expected to show a material reduction to its previously-published estimates on reserves and resources. The explorer said it expects the total reserve estimate for the field to be revised down to 250 million barrels of oil from 1.24 billion barrels previously.

AO World, up 6.6%, closed as the best mid-cap performer. The online domestic appliances retailer said website revenue rose 38% in its fiscal third quarter which includes the key Christmas trading period, with sales spiking around Black Friday but remaining strong in the run-in to the festive season. It added that it remains confident that it will meet full-year expectations.

Hikma Pharmaceuticals, up 4.3%, was another big riser in the FTSE 250. The company said it will now prepare to launch its colchicine 0.6 milligram capsules, after Takeda Pharmaceuticals USA Inc failed in its bid to block the distribution of the capsules. The US District Court for Delaware had denied Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine capsules, and Himka said Monday that Takeda was unsuccessful in appealing this decision.

In the economic calendar Tuesday, Chinese new loans and trade balances data for December will be issued at 0200 GMT. UK consumer and producer price readings for December will be at 0930 GMT. The Kantar Worldpanel will release its latest UK grocery market-share figures for the 12 weeks ending January 4 at 0930 GMT.

In the corporate calendar, supermarket Wm Morrisons Supermarkets will be issuing a trading statement, as will bakery chain Greggs and fund manager Rathbone Brothers. Department store Debenhams, pub owner Spirit Pub Co and self-storage company Big Yellow Group will provide  interim management statements. Building products distributer SIG is scheduled to release a 2014 trading statement, recruitment company Michael Page International will issue a fourth quarter trading statement, and ASOS will release a Christmas press statement.

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.